Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

1.4%

6 terminated/withdrawn out of 440 trials

Success Rate

93.2%

+6.6% vs industry average

Late-Stage Pipeline

16%

71 trials in Phase 3/4

Results Transparency

1%

1 of 82 completed trials have results

Key Signals

97 recruiting1 with results4 withdrawn

Enrollment Performance

Analytics

N/A
140(46.8%)
Phase 2
77(25.8%)
Phase 3
39(13.0%)
Phase 4
32(10.7%)
Phase 1
10(3.3%)
Early Phase 1
1(0.3%)
299Total
N/A(140)
Phase 2(77)
Phase 3(39)
Phase 4(32)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (440)

Showing 20 of 440 trials
NCT07410169Phase 2Recruiting

Efficacy and Safety of Hyperbaric Oxygen Therapy in Improving Nab-paclitaxel-Induced Peripheral Neuropathy

Role: lead

NCT07848152Recruiting

Active Surveillance and Safety/Efficacy Evaluation of Innovative Devices for Structural Heart Disease Intervention

Role: collaborator

NCT07842471Phase 2Not Yet Recruiting

Local Consolidative Therapy Versus Maintenance Immunotherapy After First-Line Chemoimmunotherapy in Metastatic NSCLC

Role: lead

NCT07722754Phase 2Recruiting

Bevacizumab, Sintilimab, Cetuximab and Irinotecan in Refractory RAS Wild-type Metastatic Colorectal Cancer: BOND-4 Trial

Role: lead

NCT07766434Recruiting

A Prospective Multicenter Real-World Registry of Quantitative Flow Ratio-Guided Coronary REvascularization and QuAlity evaLuation

Role: collaborator

NCT07483398Phase 4Active Not Recruiting

EFficacy and safEty of cRisugabalin on nocipLastic paIn in Patients With Parkinson's Disease (RELIEF-PD): a Multicentre, Double-blind, Randomised Controlled Trial

Role: lead

NCT07098351Not ApplicableRecruiting

Efficacy and Safety of Nalfurafine Hydrochloride ODT for Moderate-to-Severe Pruritus in Patients on Peritoneal Dialysis

Role: lead

NCT05339529Not ApplicableCompleted

Protective Effect of Thymosin α1 Against Negative Immune Dysregulation and Organ Dysfunction After Acute Aortic Dissection Surgery (PANDA II)

Role: collaborator

NCT04381143Phase 4Active Not Recruiting

ASPIrin in Reducing Events in Dialysis ( ASPIRED )

Role: lead

NCT05190848Recruiting

Correlation of Microbiome and Metabonomics With IgA Nephropathy

Role: lead

NCT04212494Not ApplicableRecruiting

Thrombus Aspiration in STEMI Patients With High Thrombus Burden

Role: lead

NCT06968806Phase 3Recruiting

Study on Ketorolac for Improving Outcomes and Prognosis in Patients With Stanford Type A Aortic Dissection

Role: collaborator

NCT05906719Completed

Machine Vision Based MDS-UPDRS III Machine Rating

Role: collaborator

NCT07199023Not ApplicableNot Yet Recruiting

Dietary Restriction Efficiency Assessment in CMPA

Role: collaborator

NCT07763977Not ApplicableEnrolling By Invitation

The Effects and Neural Mechanisms of Vitamin D and Iron-Immune Homeostasis on Inhibitory Control in Obsessive-Compulsive Disorder

Role: lead

NCT07746453Not ApplicableNot Yet Recruiting

Universal STAR-T Cell Injection in Autoimmune Kidney Diseases

Role: lead

NCT07752589Not Yet Recruiting

Microbiota in Neoadjuvant Chemoimmunotherapy for NSCLC

Role: lead

NCT07748260Phase 3Not Yet Recruiting

De-escalation Neoadjuvant Therapy for Intermediate Risk HER2-positive Early Breast

Role: lead

NCT06760052Recruiting

Longitudinal Data Registry of Plasma Cell Dyscrasia

Role: collaborator

NCT06215326Not ApplicableRecruiting

Short-term Effects of Preoperative Exercise in Moderate-to-high Perioperative Risk Lung Cancer Patients

Role: lead